Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Clinical trial NCT06567015 · RECRUITING

Trial details

NCT number: NCT06567015
Sponsor: Pierre Fabre Medicament
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2024-09-17
Primary completion: 2027-11-20
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.